This two-hour webinar will introduce the main concepts behind models of HIV prevention, review the state-of-the-art, and discuss the latest developments in the modeling field.
This session will explore the latest in vaccine design, development, and testing, with a focus on current trials on an efficacy pathway, as well as promising approaches in pre- or early clinical trials.
The Global HIV Vaccine Enterprise
is accelerating the development of preventive HIV vaccines through mutual coordination, collaboration, knowledge sharing and recruitment of new resources and funders to the field.
